MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Three cases of neuronal intranuclear inclusion disease (NIID)

Y. Miyamoto, Y. Morita, K. Furuta, Y. Osaki, H. Arahata, A. Watanabe, N. Fujii, T. Iwaki, H. Furuya (Kochi, Japan)

Meeting: 2016 International Congress

Abstract Number: 225

Keywords: Dementia, Mitochondrial dysfunction, Parkinsonism dementia complex(PDC), Ubiquitin proteasome system(UPS)

Session Information

Date: Monday, June 20, 2016

Session Title: Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: Here, we present three NIID cases. One of them, autopsy was performed.

Background: Neuronal intranuclear inclusion disease (NIID)(OMIM 603472) is a neurodegenerative disorder characterized by eosinophilic intranuclear inclusions in neuronal cells. Such inclusions are also found in non-neuronal cells. The clinical features and pathological findings in patients with NIID are highly varied.

Methods: Case 1 and 2 are adult onset NIID and case 3 is a juvenile onset. Case 1 is diagnosed as familial adult onset Parkinson’s disease with dementia, and case 2 is diagnosed as sporadic mild parkinsonism with dementia and psychosis. Case 3 is a juvenile onset familial case and diagnosed as oculopharyngeal muscular dystrophy (OPMD) with mental deterioration by muscle biopsy. Autopsy was performed after sudden death at age 42.

Results: In MRI imaging, diffuse cerebral atrophy was observed in all cases. High intensity of the cortico-medullary junction in diffusion-weighted imaging (DWI), which is characteristic findings in NIID, was seen in two adult onset cases. Ante-mortem diagnosis was made by identification of intranuclear inclusions with skin biopsy in two adult onset cases. Post-mortem diagnosis was made in juvenile case. In this case, acidophilic intranuclear inclusion body with positive p62 immune staining was observed, not only in neuron and glia cell, but all other organ tissues.

Conclusions: Intranuclear accumulation of abnormal proteins and/or dysfunction of protein degradation might underlie in the pathogenesis of NIID. However, NIID is considered as a heterogeneous disease entity and shows various clinical features. Not only neurologist, but also psychiatrist and pediatrician should pay attention to this heterogeneous disorder.

To cite this abstract in AMA style:

Y. Miyamoto, Y. Morita, K. Furuta, Y. Osaki, H. Arahata, A. Watanabe, N. Fujii, T. Iwaki, H. Furuya. Three cases of neuronal intranuclear inclusion disease (NIID) [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/three-cases-of-neuronal-intranuclear-inclusion-disease-niid/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/three-cases-of-neuronal-intranuclear-inclusion-disease-niid/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley